PHARMACYTE BIOTECH, INC. Marketable Securities, Unrealized Gain (Loss)
PHARMACYTE BIOTECH, INC. (PMCB) reported Marketable Securities, Unrealized Gain (Loss) of -$154.55 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-07-31 was -$154.55K.
- PHARMACYTE BIOTECH, INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-04-30 was -$118.24K.
- PHARMACYTE BIOTECH, INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-01-31 was -$128.94K, a 277.52% decline year-over-year.
- PHARMACYTE BIOTECH, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-10-31 was -$60.66K.
- PHARMACYTE BIOTECH, INC. marketable securities, unrealized gain (loss) for fiscal 2026 was -$412.31K, a 721.73% decline from fiscal 2025.
- PHARMACYTE BIOTECH, INC. marketable securities, unrealized gain (loss) for fiscal 2025 was $66.32K.
- PHARMACYTE BIOTECH, INC. marketable securities, unrealized gain (loss) for fiscal 2024 was $0.00.
| Period end | Marketable Securities, Unrealized Gain (Loss) 2 month | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2026-07-31 | -$154.55K 10-Q · filed 2026-09-14 | -$272.79K derived: sum of 2 quarters · filed 2026-09-14 | -$401.73K derived: sum of 3 quarters · filed 2026-09-14 | -$462.39K derived: sum of 4 quarters · filed 2026-09-14 | |
| 2026-04-30 | -$118.24K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$247.18K derived: sum of 2 quarters · filed 2026-07-29 | -$307.84K derived: sum of 3 quarters · filed 2026-07-29 | -$412.31K 10-K · filed 2026-07-29 | |
| 2026-01-31 | -$128.94K 10-Q · filed 2026-03-17 | -$189.60K derived: sum of 2 quarters · filed 2026-03-17 | -$294.06K 10-Q · filed 2026-03-17 | -$300.38K derived: sum of 4 quarters · filed 2026-09-14 | |
| 2025-10-31 | -$60.66K 10-Q · filed 2025-12-18 | -$165.13K 10-Q · filed 2025-12-18 | -$171.44K derived: sum of 3 quarters · filed 2026-09-14 | -$98.81K derived: sum of 4 quarters · filed 2026-09-14 | |
| 2025-07-31 | -$104.46K 10-Q · filed 2026-09-14 | -$110.78K derived: sum of 2 quarters · filed 2026-09-14 | -$38.15K derived: sum of 3 quarters · filed 2026-09-14 | -$38.15K derived: sum of 4 quarters · filed 2026-09-14 | |
| 2025-04-30 | -$6.32K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $66.32K derived: sum of 2 quarters · filed 2026-07-29 | $66.32K derived: sum of 3 quarters · filed 2026-07-29 | $66.32K 10-K · filed 2026-07-29 | |
| 2025-01-31 | $72.63K 10-Q · filed 2025-03-17 | $72.63K 10-Q · filed 2026-03-17 | $72.63K derived: sum of 2 quarters · filed 2026-03-17 | $72.63K 10-Q · filed 2026-03-17 | $72.63K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-10-31 | $0.00 10-Q · filed 2025-12-18 | $0.00 10-Q · filed 2025-12-18 | $0.00 derived: sum of 3 quarters · filed 2025-12-18 | $0.00 derived: sum of 4 quarters · filed 2025-12-18 | |
| 2024-07-31 | $0.00 10-Q · filed 2025-09-15 | $0.00 derived: sum of 2 quarters · filed 2025-09-15 | $0.00 derived: sum of 3 quarters · filed 2025-09-15 | ||
| 2024-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | $0.00 derived: sum of 2 quarters · filed 2025-08-11 | $0.00 10-K · filed 2025-08-11 | ||
| 2024-01-31 | $0.00 10-Q · filed 2025-03-17 | $0.00 10-Q · filed 2025-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |